Zilla H. Hussain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zilla H. Hussain has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Brian E Lacy
Division of Gastroenterology and Hepatology, Area 4C, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA
2 shared publicationsB. E. Lacy
Division of Gastroenterology & Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
1 shared publicationBrian E. Lacy
Dartmouth-Hitchcock Medical Center
1 shared publication- Brian E. Lacy
Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
1 shared publication Carla Maradey-Romerao
Metro West Medical Center, Cleveland, Ohio, USA
1 shared publicationDiana A. Whitehead
Dartmouth-Hitchcock Medical Center
1 shared publication
Latest Publications
- Open Access
- 1 August 2015
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 6 (8) , e106
The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum
Gastroesophageal reflux disease (GERD) is a highly prevalent chronic condition where in stomach contents reflux into the esophagus causing symptoms, esophageal injury, and subsequent complications. Proton pump inhibitors (PPI) remain the mainstay of therapy for acid suppression. Despite their effica
- 1 August 2015
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 6 (8) , e106
Open AccessThe Proton Pump Inhibitor Non-Responder: A Clinical Conundrum
Gastroesophageal reflux disease (GERD) is a highly prevalent chronic condition where in stomach contents reflux into the esophagus causing symptoms, esophageal injury, and subsequent complications. Proton pump inhibitors (PPI) remain the mainstay of therapy for acid suppression. Despite their effica
- 1 February 2015
- Vol. 11 (2) , 104-14
Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.
Constipation is a highly prevalent disorder that affects people regardless of age, race, gender, or socioeconomic status. For many patients, constipation is a chronic condition that reduces quality of life. Chronic constipation also imposes a significant economic burden on the health care system. The treatment of constipation remains problematic for both patients and providers for a variety of reasons, including a lack of specificity of symptoms, an inconsistent relationship between underlying pathophysiology and symptom generation, and different and unpredictable patient responses to medications. A large number of over-the-counter agents are used to treat symptoms of constipation, although many of these agents are not effective, and data to support their use are limited and generally of poor quality. Patients referred for consultation typically have failed therapy with over-the-counter agents and require prescription medications or possibly even surgical therapy. This article discusses medical treatments and surgical options for chronic idiopathic constipation.
- 1 February 2015
- Vol. 11 (2) , 104-14
Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.
Constipation is a highly prevalent disorder that affects people regardless of age, race, gender, or socioeconomic status. For many patients, constipation is a chronic condition that reduces quality of life. Chronic constipation also imposes a significant economic burden on the health care system. The treatment of constipation remains problematic for both patients and providers for a variety of reasons, including a lack of specificity of symptoms, an inconsistent relationship between underlying pathophysiology and symptom generation, and different and unpredictable patient responses to medications. A large number of over-the-counter agents are used to treat symptoms of constipation, although many of these agents are not effective, and data to support their use are limited and generally of poor quality. Patients referred for consultation typically have failed therapy with over-the-counter agents and require prescription medications or possibly even surgical therapy. This article discusses medical treatments and surgical options for chronic idiopathic constipation.
- 16 September 2014
- Published by Springer Nature
- p. 239-250
Rectal Pain
- 12 August 2014
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 16 (9) , 1-7
Fecal Impaction
Fecal impaction (FI) is a common and potentially serious medical condition that occurs in all age groups. Children, incapacitated patients, and the institutionalized elderly are considered the highest at-risk populations. FI usually occurs in the setting of chronic or severe constipation, anatomic anorectal abnormalities, and neurogenic or functional gastrointestinal disorders. Generally, FI is a preventable disorder, and early recognition is important, as it is associated with increased morbidity, mortality, and high health care costs. Evaluation with a careful history and physical examination, in conjunction with radiologic imaging, such as an acute abdominal series or computed tomography (CT), is imperative. Prompt identification and treatment minimize the risk of complications attributable to FI, which may include bowel obstruction leading to stercoral ulcer, perforation, peritonitis, or cardiopulmonary collapse with hemodynamic instability. Treatment options include manual fragmentation and extraction of the fecal mass, distal colonic cleansing using enemas and rectal lavage with the aid of a sigmoidoscope, and/or using water-soluble contrast media such as Gastrografin to both identify the extent of the impaction and aid in cleansing and removal. Surgical resection of the involved colon or rectum is reserved for peritonitis resulting from bowel perforation. Since recurrence is common, implementing preventive measures such as increasing daily water and fiber intake, limiting medications that decrease colonic motility, using secretagogues or prokinetic agents, and treating underlying anatomic defects are highly important.
- 12 August 2014
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 16 (9) , 1-7
Fecal Impaction
Fecal impaction (FI) is a common and potentially serious medical condition that occurs in all age groups. Children, incapacitated patients, and the institutionalized elderly are considered the highest at-risk populations. FI usually occurs in the setting of chronic or severe constipation, anatomic anorectal abnormalities, and neurogenic or functional gastrointestinal disorders. Generally, FI is a preventable disorder, and early recognition is important, as it is associated with increased morbidity, mortality, and high health care costs. Evaluation with a careful history and physical examination, in conjunction with radiologic imaging, such as an acute abdominal series or computed tomography (CT), is imperative. Prompt identification and treatment minimize the risk of complications attributable to FI, which may include bowel obstruction leading to stercoral ulcer, perforation, peritonitis, or cardiopulmonary collapse with hemodynamic instability. Treatment options include manual fragmentation and extraction of the fecal mass, distal colonic cleansing using enemas and rectal lavage with the aid of a sigmoidoscope, and/or using water-soluble contrast media such as Gastrografin to both identify the extent of the impaction and aid in cleansing and removal. Surgical resection of the involved colon or rectum is reserved for peritonitis resulting from bowel perforation. Since recurrence is common, implementing preventive measures such as increasing daily water and fiber intake, limiting medications that decrease colonic motility, using secretagogues or prokinetic agents, and treating underlying anatomic defects are highly important.
- 23 May 2014
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 26 (6) , 749-763
Treatment for constipation: New and old pharmacological strategies
Background: Constipation is a very common entity. Despite the high prevalence, treatment of constipation remains problematic.Purpose: Review the current literature on new and existing constipation treatment modalities.
- 23 May 2014
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 26 (6) , 749-763
Treatment for constipation: New and old pharmacological strategies
Background: Constipation is a very common entity. Despite the high prevalence, treatment of constipation remains problematic.Purpose: Review the current literature on new and existing constipation treatment modalities.